Professor Noemi Lois awarded Edinburgh King James IV Professorship by The Royal College of Surgeons

News
Article

Professor Lois accepted the award at the Royal College of Ophthalmologists Annual Congress

Professor Noemi Lois. Image courtesy of Queen's University Belfast.

Professor Noemi Lois was specifically recognised for her work on the DIAMONDS clinical trial. Image courtesy of Queen's University Belfast.

At the 2024 Royal College of Ophthalmologists (RCOphth) Annual Congress, Noemi Lois, MD, PhD, FRCS(Ed), FRCOphth, was awarded The Royal College of Surgeons of Edinburgh King James IV Professorship. She is Professor of Ophthalmology at Queen’s University Belfast, where she leads a preclinical and clinical research programme focused on diabetic retinopathy.1 In a news release, the award was described as the most senior academic award made by the College. Professor Lois was honoured for her many contributions to retinal surgery, specifically as chief investigator of the Diabetic Macular Oedema aNd Diode Subthreshold micropulse laser (DIAMONDS) multicentre clinical trial.

"I am thoroughly delighted to receive this very precious award, which means a lot to me,” Professor Lois said in the news release.1 “The Royal College of Surgeons of Edinburgh generously funded a great deal of experimental research I undertook while a full time Consultant Ophthalmologist in Aberdeen and I will be always indebted to them for their support.”

Professor Lois joined Queen’s University Belfast in 2013, where she is a Clinical Professor of Ophthalmology in the Wellcome-Wolfson Institute for Experimental Medicine. She is also an Honorary Consultant Ophthalmologist and Vitreoretinal Surgeon at the Belfast Health and Social Care Trust.

The DIAMONDS trial, funded by the National Institute for Health and Care Research, recruited 266 UK participants with diabetic macular oedema (DME). Patients were treated with a novel macular laser treatment, subthreshold micropulse macular laser. The treatment was found to be as effective as standard macular lasers for preserving sight in patients with DME. Professor Lois is also leading a large clinical trial which aims to introduce a new alternative technique for monitoring DME and proliferative diabetic retinopathy.2

References


1. Queen’s academic awarded prestigious Professorship. News release. Queen's University Belfast. Published 21 May, 2024. Accessed 22 May, 2024. https://www.qub.ac.uk/News/Allnews/2024/QueensacademicawardedprestigiousProfessorship.html
2. Professor Noemi Lois, Clinical Professor of Ophthalmology. Queen's University Belfast. Accessed 22 May, 2024. https://www.qub.ac.uk/News/find-an-expert/ProfessorNoemiLois.html

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
© 2025 MJH Life Sciences

All rights reserved.